A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, is a common treatment for rheumatoid arthritis and other types of joint inflammation.
“We had hoped that this approach to the treatment of Wegener’s granulomatosis would be useful in preventing disease relapses,” says John H. Stone, M.D., associate professor of medicine, director of the Johns Hopkins Vasculitis Center, and lead investigator of the study published in the Jan. 27, 2005, issue of the New England Journal of Medicine.
The rest of this article is here.
In short, Etanercept does not work for WG patients.
My Analysis: Research is good in finding what works for chronic illness. Too bad that this medication will not help WG patients. However, it is another step towards some medication that can help us.